Van life (cancer edition) finale
Although it is completely your decision, I wanted to refer you to a contact at MSKCC who is developing mesothelin-targeted CAR-T therapy. It is worth calling or emailing to see if you could be considered: Roisin O'Cearbhail, MD 646-608-3742 cart@mskcc.org<p>As a pharmacist who works in research, if I had a refractory cancer, this is the kind of therapy I would want for myself as a last shot at survival.